EV Biologics, Inc. (YECO)

USD 0.14

(0.0%)

Total Debt Summary of EV Biologics, Inc.

  • EV Biologics, Inc.'s latest annual total debt in 2023 was 1.49 Million USD , down -93.41% from previous year.
  • EV Biologics, Inc.'s latest quarterly total debt in 2024 Q3 was 1.49 Million USD , down -0.15% from previous quarter.
  • EV Biologics, Inc. reported annual total debt of 22.67 Million USD in 2022, up 4.59% from previous year.
  • EV Biologics, Inc. reported annual total debt of 21.68 Million USD in 2021, down 0.0% from previous year.
  • EV Biologics, Inc. reported quarterly total debt of 1.49 Million USD for 2024 Q1, up 0.08% from previous quarter.
  • EV Biologics, Inc. reported quarterly total debt of 1.49 Million USD for 2024 Q3, down -0.15% from previous quarter.

Annual Total Debt Chart of EV Biologics, Inc. (2023 - 2013)

Historical Annual Total Debt of EV Biologics, Inc. (2023 - 2013)

Year Total Debt Total Debt Growth
2023 1.49 Million USD -93.41%
2022 22.67 Million USD 4.59%
2021 21.68 Million USD 0.0%
2020 - USD -100.0%
2019 10.03 Million USD 0.0%
2017 6.46 Million USD -33.76%
2016 9.76 Million USD -23.27%
2015 12.72 Million USD 34.95%
2014 9.43 Million USD -13.15%
2013 10.85 Million USD 0.0%

Peer Total Debt Comparison of EV Biologics, Inc.

Name Total Debt Total Debt Difference
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 96.372%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 63.737%
SQZ Biotechnologies Company 27.47 Million USD 94.559%
Evofem Biosciences, Inc. 43.37 Million USD 96.554%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 94.979%
Mesoblast Limited 118.7 Million USD 98.741%
Propanc Biopharma, Inc. 948.27 Thousand USD -57.629%
Genus plc 233.1 Million USD 99.359%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 48.991%
CNBX Pharmaceuticals Inc. 1.34 Million USD -11.251%
Marizyme, Inc. 18.71 Million USD 92.014%
ContraFect Corporation 2.88 Million USD 48.117%
Nymox Pharmaceutical Corporation 750 Thousand USD -99.3%
PsyBio Therapeutics Corp. 135.48 Thousand USD -1003.243%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD -3.349%
Intellipharmaceutics International Inc. 2.32 Million USD 35.736%
AXIM Biotechnologies, Inc. 5.65 Million USD 73.583%
MultiCell Technologies, Inc. 202.58 USD -737757.143%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 57.48 Million USD 97.4%
Q BioMed Inc. 4.1 Million USD 63.631%
Emmaus Life Sciences, Inc. 33.1 Million USD 95.484%
Neon Bloom, Inc. 630.07 Thousand USD -137.233%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -21.687%
Biomind Labs Inc. 735.54 Thousand USD -103.218%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 171.54 Million USD 99.129%
Oncotelic Therapeutics, Inc. 12.99 Million USD 88.499%
Skye Bioscience, Inc. 4.61 Million USD 67.613%
Therapeutic Solutions International, Inc. 888.06 Thousand USD -68.316%
THC Farmaceuticals, Inc. 141.51 Thousand USD -956.227%
Arch Therapeutics, Inc. 5.87 Million USD 74.54%
IMV Inc. 28.88 Million USD 94.825%
Acro Biomedical Co., Ltd. 25.71 Thousand USD -5711.855%
Curative Biotechnology, Inc. 2.25 Million USD 33.813%
GB Sciences, Inc. 1.75 Million USD 15.038%
Alpha Cognition Inc. 1.22 Million USD -22.483%
HST Global, Inc. 98.31 Thousand USD -1420.307%
CSL Limited 12.18 Billion USD 99.988%
Halberd Corporation 150 Thousand USD -896.501%
Enzolytics Inc. 996.33 Thousand USD -50.024%
Resverlogix Corp. 6.49 Million USD 76.972%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 477.5 Thousand USD -213.037%
Nuo Therapeutics, Inc. 255.59 Thousand USD -484.819%
argenx SE 20 Million USD 92.526%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 45.56 Million USD 96.719%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 44.817%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -14518.592%
Genscript Biotech Corporation 417.73 Million USD 99.642%
Ember Therapeutics, Inc. 200.61 Thousand USD -645.081%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 37.66%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -551.901%
American Oriental Bioengineering, Inc. 67.64 Million USD 97.79%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 50.606%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation 359.71 Thousand USD -315.543%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 92.647%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD -905.524%
BioStem Technologies, Inc. 4.71 Million USD 68.274%
ONE Bio Corp. 19.71 Million USD 92.418%
Reve Technologies, Inc. 250.18 Thousand USD -497.465%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD -500.977%
Agentix Corp. 50 Thousand USD -2889.502%
LadRx Corporation 33.6 Thousand USD -4347.869%
Cell Source, Inc. 9.25 Million USD 83.848%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD -97.665%
Regen BioPharma, Inc. 756.2 Thousand USD -97.665%
NovAccess Global Inc. 2.19 Million USD 32.053%
Endonovo Therapeutics, Inc. 7.07 Million USD 78.866%
Itoco Inc. 228.37 Thousand USD -554.51%
Rasna Therapeutics, Inc. 210.97 Thousand USD -608.497%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 70.003%
Kadimastem Ltd 891.22 Thousand USD -67.719%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. 401.84 Thousand USD -271.968%
CytoDyn Inc. 30.07 Million USD 95.03%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD -208.652%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD -324.83%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 80.885%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD -1120.205%
Rebus Holdings, Inc. 310 Thousand USD -382.178%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 68.434%
International Stem Cell Corporation 4.17 Million USD 64.223%
Bioxytran, Inc. 1.92 Million USD 22.351%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD -2294.935%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 31.462%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 82.026%
Adhera Therapeutics, Inc. 8.58 Million USD 82.589%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 3.904%
Innovation Pharmaceuticals Inc. 268 Thousand USD -457.743%
Neutra Corp. 54.15 Thousand USD -2660.084%
Windtree Therapeutics, Inc. 1.83 Million USD 18.32%
PureTech Health plc 25.51 Million USD 94.141%
Coeptis Therapeutics, Inc. 1.22 Million USD -22.098%
IXICO plc 472.02 Thousand USD -216.669%
IntelGenx Technologies Corp. 15.5 Million USD 90.357%
Gelesis Holdings, Inc. 62.26 Million USD 97.599%
CSL Limited 12.18 Billion USD 99.988%
Cellectis S.A. 92.77 Million USD 98.389%